This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie policy for more information on the cookies we use and how to delete or block them.

Ok, Got It
News, stories and opinions for the business innovators of the world.

Atmo Biosciences.

Atmo Biosciences, a digital health company that is developing the world’s first ingestible gas-sensing capsule for monitoring gut health, has closed an oversubscribed A$9.6m capital raise.

Suraya SalehMarketing Communications Manager
Topics.

Planet Innovation’s unique ‘strategic investor’ approach proves a winner

Planet Innovation is redefining what it means to be a strategic investor by providing investee companies with not just funding, but access to its people, facilities and networks.

Prime Minister Scott Morrison congratulates PI on its “tremendous success” during tour of expanded facility

Prime Minister Scott Morrison and Federal Member for Chisholm Gladys Liu visited Planet Innovation to tour our expanded manufacturing and design facilities, and discuss the recently announced Patent Box tax incentive.

Atmo Biosciences ramps up production of ingestible gas-sensing capsule at PI’s new manufacturing facility

Atmo Biosciences is ramping up manufacture of its third generation gas-sensing capsule at Planet Innovation’s recently opened new medtech manufacturing facility.

Atmo Biosciences wins $620k grant to advance commercialization of ingestible gas-sensing capsule to diagnose gut disorders

Atmo Biosciences has been awarded a $620,000 Australian Government grant through the BioMedTech Horizons (BMTH) program.

Atmo Biosciences raises $2.5m in seed financing

Atmo Biosciences, a digital health business that provides objective real-time insights into gut health and microbiome function, has raised a further A$2.5 million in an oversubscribed funding round, supplementing an initial seed raise in March 2019.

Atmo Biosciences and Seed Health announce research partnership to evaluate impact of probiotics on gut microbiome

Seed Health, a US-based microbial sciences company, and Atmo Biosciences, a Planet Innovation early stage venture, have announced a partnership to use Atmo’s ingestible gas-sensing capsule to study the impact of probiotics on the gut microbiome.

PI launches Atmo Biosciences to commercialize ingestible gas-sensing capsule for gut health

Atmo Biosciences, a Planet Innovation early stage venture, has signed a licensing deal with RMIT University to secure the exclusive worldwide rights to a ground-breaking ingestible gas-sensing capsule.

Sign up for the Perspectives newsletter:

A roundup of the latest news and opinions from PI.